Qiming U.S. Healthcare Fund Ii, L.P. Elevation Oncology, Inc. (ELEV) insider trading activity

Qiming U.S. Healthcare Fund Ii, L.P. is > 10% Shareholder of Elevation Oncology, Inc.. Currently has a direct ownership of 2.37 Million shares of ELEV, which is worth approximately $6.64 Million. The most recent transaction as insider was on Jun 29, 2021, when has been sold 312,500 shares (Common Stock) at a price of $16.0 per share, resulting in proceeds of $5,000,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.37M

0% 3M change

0% 12M change

Total Value Held $6.64 Million

Qiming U.S. Healthcare Fund II, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 29 2021	BUY Open market or private purchase	$5,000,000 $16.0 p/Share	312,500 Added 11.65%	2,370,142 Common Stock
Jun 29 2021	BUY Conversion of derivative security	-	2,057,642 Added 50.0%	2,057,642 Common Stock

Also insider at

ICVX

Icosavax, Inc. Healthcare

JSPR

Jasper Therapeutics, Inc. Healthcare

> 10% Shareholder

QUH